Barry Potter

Barry Potter serves as a Visiting Professor in the Department of Life Sciences, with extensive research contributions spanning medicinal chemistry, chemical biology, and drug discovery. His work focuses on enzyme inhibitors, particularly targeting steroid sulfatase and inositol phosphate pathways, with significant implications for breast cancer therapeutics and cellular signaling research.

Dr. Potter's research interests center on the development of enzyme inhibitors targeting sulfatase enzymes, inositol phosphate metabolism, and kinase regulation. His work demonstrates expertise in structure-activity relationship studies, chemical synthesis of novel compounds, and the biochemical characterization of enzyme mechanisms. His fingerprint analysis reveals dominant research areas including Sulfamate (100%), Steryl Sulfatase (79%), Inositol (61%), Structure Activity Relationship (56%), Breast Cancer (44%), and Steroid Sulfatase (42%).

Analysis of his recent publications shows a consistent focus on enzyme-ligand interactions and drug design, with particular emphasis on developing inhibitors for cancer-related targets. His work bridges chemical synthesis with biological evaluation, demonstrating strong translational potential in oncology and infectious disease treatment. The publications reveal expertise in both structural biology approaches and medicinal chemistry optimization strategies.

Dr. Potter has successfully secured multiple research grants from The Wellcome Trust, totaling four major projects between 2007-2018. These include "Chemical Biology of Cellular Signalling using Polyphosphate Messengers" (2014-2018), "Cyclic Adenosine Diphosphoribose (cADPR) and Adenosine (ADPR) analogues in human T-lymphocyte chemical biology" (2008-2013), and "CHEMICAL BIOLOGY, INOSITOL PHOSPHATES AND CELL SIGNALLING" (2007-2014), demonstrating his leadership in securing substantial research funding.

Dr. Potter has supervised at least four research projects as indicated by the "Supervised Work (4)" notation. His research has generated significant scholarly impact with 527 research outputs including 481 articles, 22 patents, 17 book chapters, and other scholarly contributions. His work has been widely disseminated through academic publications and has attracted attention across multiple social media platforms and news outlets.